Dr. Agarwals Health Care Ltd shares in focus as SEBI takeover disclosure received for Catalyst Trusteeship
Why did Dr. Agarwals Health Care Ltd shares jump today?
Dr. Agarwals Health Care Ltd shares experienced a noticeable jump today, rising by 0.75% to a current price of ₹500.95 as of 03:26 PM on Tuesday. This increase in share price reflects positive market reaction to recent company-related news, drawing interest from investors tracking the stock's performance.
The catalyst for this movement appears to be a disclosure received by the stock exchanges from Catalyst Trusteeship Limited. Acting as an Onshore Security Agent, the company filed a disclosure under Regulation 29(2) of the SEBI Takeover Regulations. This filing pertains to a facility agreement dated March 26, 2024, in which Hyperion Investments Pte. Ltd. pledged a substantial number of shares—73,193,988 equity shares of Dr. Agarwals Health Care—to secure a loan facility of up to USD 100 million.
In simple terms, this disclosure informs the market about a major financial arrangement involving the company's shares. Such regulatory filings are crucial for transparency and can impact investor confidence. The news likely boosted today's share price as it highlights ongoing financial activities and stakeholder engagements that may signal stability or growth prospects for the company. Investors often watch these updates closely to gauge the broader implications for the stock's value.
What does Dr. Agarwals Health Care Ltd do?
Dr. Agarwals Health Care Ltd is a healthcare company headquartered at 1st Floor, Buhari Towers, No. 4, Moores Road, off Greams Road, Near Asan Memorial School, Chennai, Tamil Nadu. The company is involved in a financial arrangement wherein 73,193,988 of its equity shares have been pledged.
These shares were pledged by a borrower, Hyperion Investments Pte. Ltd., as security for a loan facility aggregating up to USD 100,000,000. The company is identified as the "Target Company" within the context of this share pledge agreement.
Dr. Agarwals Health Care Ltd Financials
In CroresDr. Agarwals Health Care Ltd. demonstrated positive financial momentum between the quarters ending March 2026 and June 2026. The company's revenue grew from ₹564.11 Crores to ₹614.02 Crores, marking an increase of approximately 8.85%. Concurrently, its profit also expanded, rising from ₹39.71 Crores to ₹45.23 Crores, which represents a growth of about 13.9% over the same period. This indicates an upward trend in both top-line and bottom-line performance for the reported quarters.
Dr. Agarwals Health Care Ltd Shareholding Pattern
Promoter holding stands at 32.34% of the total share capital. Foreign Institutional Investors (FIIs) hold 57.97% stake in the company, while Domestic Institutional Investors (DIIs) hold 7.72%. Public shareholders hold the remaining 1.97% stake in Dr. Agarwals Health Care Ltd.
Dr. Agarwals Health Care Ltd FAQs
Q: Why did Dr. shares jump 0.75% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Dr. Agarwals Health Care Ltd?
As per the latest data, promoters hold 32.34% stake in Dr. Agarwals Health Care Ltd, while FII holding stands at 57.97%. Domestic institutional investors hold 7.72%, and public shareholders account for 1.97% of the equity.
Q: What is the current stock price of Dr. Agarwals Health Care Ltd?
Dr. Agarwals Health Care Ltd shares are currently trading at ₹500.95, recording a gain of 0.75% from the previous close.
Q: What is the market capitalization of Dr. Agarwals Health Care Ltd?
The company currently has a market capitalization of ₹15879.27 crore, reflecting its valuation in the Indian equity market.